Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» M&A
M&A
Accelmed in talks to buy US spinal therapy co
Mon, 02/20/12 - 10:25 pm
Accelmed
Spinal
M&A
DNA in Play as Life Technologies Joins Illumina in Race for Deal: Real M&A
Mon, 02/20/12 - 10:22 pm
DNA
Life Technologies
Illumina
M&A
Theragenics acquires Core Oncology’s prostate brachytherapy customer base
Mon, 02/20/12 - 10:12 pm
Theragenics
Core
market
M&A
[video] Idenix Pharmaceuticals Is Looking For Partners
TheStreet.com
Thu, 02/16/12 - 05:23 pm
Indenix
M&A
Acorda 4Q profit climbs; company buying Neuronex
Yahoo/AP
Thu, 02/16/12 - 05:23 pm
Neuronex
M&A
earnings
Acorda
FTC ends review of Amgen's purchase of Micromet
Yahoo/AP
Thu, 02/16/12 - 09:31 am
Amgen
Micromet
FTC
M&A
Thermo Fisher Targeting Pay Down on Debt, Bolt-on Acquisitions, CEO Says
Wed, 02/15/12 - 10:49 pm
Thermo Fisher
CEO
M&A
Drugmakers Seek Deals to Gain Share of Future Hepatitis C Combination Pill
Bloomberg
Wed, 02/15/12 - 08:55 am
M&A
Inhibitex
Indenix
hepatitis C
Bristol-Myers Squibb
Achillion
Baxter Completes Acquisition of Synovis
Tue, 02/14/12 - 10:03 pm
Baxter
Synosia Therapeutics
M&A
J&J tries to ease EU concerns on Synthes buy
Reuters
Tue, 02/14/12 - 04:55 pm
JNJ
Synthes
Europe
M&A
Biogen Idec scores lung disease drug in $562.5M buyout of Stromedix
Fierce Biotech
Tue, 02/14/12 - 11:18 am
Stromedix
Biogen Idec
M&A
STX-100
fibrosis
Valeant Pharmaceuticals to buy Eyetech
Reuters
Mon, 02/13/12 - 10:27 am
Valeant Pharmaceuticals
M&A
Eyetech
Bristol-Myers Squibb Announces Successful Completion of Cash Tender Offer for Shares of Inhibitex, Inc.
Yahoo
Mon, 02/13/12 - 10:26 am
Inhibitex
Bristol-Myers Squibb
M&A
Watson CEO Seeks Brand-Drug Profits in Shift From Copycats
Bloomberg
Thu, 02/9/12 - 11:49 am
Watson
Pharma CEOs
generics
Paul Bisaro
M&A
branded pharma
Semantics Suggest Higher Bid Ahead for Illumina: Finerman
CNBC
Thu, 02/9/12 - 09:28 am
Illumina
M&A
Roche
Roche disappointed by Illumina bid rejection
Reuters
Wed, 02/8/12 - 09:33 am
Illumina
M&A
Roche
Illumina board rejects Roche's hostile offer
Marketwatch
Tue, 02/7/12 - 04:39 pm
Roche
Illumina
M&A
hostile bid
India's Piramal Healthcare to borrow for future buys
Reuters
Mon, 02/6/12 - 09:44 am
Piramal Healthcare
M&A
India
Are WuXi PharmaTech and ShangPharma M&A Targets?
Seeking Alpha
Thu, 02/2/12 - 03:00 pm
China
M&A
WuXi PharmaTech
ShangPharma
New CEO = Dendreon Takeover Target?
Motley Fool
Thu, 02/2/12 - 10:09 am
Dendreon
M&A
Pharma CEOs
Savient
John Johnson
Pages
« first
‹ previous
…
256
257
258
259
260
261
262
263
264
…
next ›
last »